DRUG DEVELOPMENT PIPELINE

Back to the Drug Development Pipeline

POL6014

Phase One

Phase One

Therapeutic Approach

Anti-Inflammatory

This program is studying a compound designed to block the function of neutrophil elastase. Neutrophil elastase is a type of protein associated with inflammation in the lungs. Blocking the function of neutrophil elastase may minimise tissue destruction and decrease inflammation within the CF airway. 

Status

Phase 1 studies to test the safety of this compound are underway in Europe. 

Sponsor

This program is sponsored by Polyphor and partially funded by Cystic Fibrosis Foundation Therapeutics (CFFT). 

Contact us about POL6014 >